
Fleming Biopharmaceutical is a national high-tech enterprise integrating production, academia, research, and sales, specializing in innovative applications and product development of recombinant proteins in wound repair, reproductive health, and beauty anti-aging. The company collaborates with top research institutions such as the Chinese Academy of Sciences National Laboratory, Chinese Biopharmaceutical Research Institute, and South China University of Technology. It uses synthetic biology principles, gene engineering, and AI-assisted design to develop high-purity, high-efficacy recombinant fusion proteins. Fleming has obtained international gene protein database inclusion, INCI names, and National Medical Products Administration registration for medical device raw materials. It has launched multiple recombinant protein innovative products including PHPV gel and type I collagen gel dressings, and holds EU CE certification for its disinfectant products, positioning it as a leader in synthetic biology recombinant protein innovation with expanding international market presence.

Fleming Biopharmaceutical is a national high-tech enterprise integrating production, academia, research, and sales, specializing in innovative applications and product development of recombinant proteins in wound repair, reproductive health, and beauty anti-aging. The company collaborates with top research institutions such as the Chinese Academy of Sciences National Laboratory, Chinese Biopharmaceutical Research Institute, and South China University of Technology. It uses synthetic biology principles, gene engineering, and AI-assisted design to develop high-purity, high-efficacy recombinant fusion proteins. Fleming has obtained international gene protein database inclusion, INCI names, and National Medical Products Administration registration for medical device raw materials. It has launched multiple recombinant protein innovative products including PHPV gel and type I collagen gel dressings, and holds EU CE certification for its disinfectant products, positioning it as a leader in synthetic biology recombinant protein innovation with expanding international market presence.